Bookmark and Share

Compound Summary for: CID 3034010

orlistat

Also known as: Tetrahydrolipstatin, Orlipastat, Xenical, Alli, 96829-58-2, (-)-Tetrahydrolipstatin, Orlipastatum, Orlipastatum [INN-Latin]
Molecular Formula: C29H53NO5   Molecular Weight: 495.73482   InChIKey: AHLBNYSZXLDEJQ-FWEHEUNISA-N
Orlistat is a drug designed to treat obesity. Its primary function is preventing the absorption of fats from the human diet, thereby reducing caloric intake. Orlistat works by inhibiting pancreatic lipase, an enzyme that breaks down triglycerides in the intestine. Without this enzyme, triglycerides from the diet are prevented from being hydrolyzed into absorbable free fatty acids and are excreted undigested.   From: DrugBank
Show subcontent titlesTable of Contents
Identification
Related Records
show all 3 sub-sections (Related Compounds with Annotation, Related Compounds, Related Substances)
Use and Manufacturing
Pharmacology
Biomedical Effects and Toxicity
Safety and Handling
Environmental Fate and Exposure Potential
Exposure Standards and Regulations
Monitoring and Analysis Methods
Literature
Patents
Biomolecular Interactions and Pathways
Biological Test Results
Classification
Chemical and Physical Properties
_ _